CMAJ • January 30, 2007; 176 (3). doi:10.1503/cmaj.050816.
© 2007 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khan, A. A.
Right arrow Articles by Olszynski, W. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khan, A. A.
Right arrow Articles by Olszynski, W. P.
Related Collections
Right arrow Osteoporosis
Right arrowRelated Articles

Management of osteoporosis in men: an update and case example

Aliya A. Khan, Anthony B. Hodsman, Alexandra Papaioannou, David Kendler, Jacques P. Brown and Wojciech P. Olszynski

From the Divisions of Endocrinology and Geriatrics (Khan) and Geriatric Medicine (Papaioannou), Department of Medicine, McMaster University, Hamilton; Divisions of Endocrinology and Nephrology (Hodsman), Department of Medicine, University of Western Ontario, London, Ont.; Division of Endocrinology (Kendler), Department of Medicine, University of British Columbia, Vancouver, BC; Division of Rheumatology (Brown), Department of Clinical Medicine, Laval University, Quebec City, Que.; and Division of Rheumatology (Olszynski), Department of Clinical Medicine, University of Saskatchewan, Saskatoon, Man.


Figure 123
View larger version (72K):
[in this window]
[in a new window]

  		Box 1.

 

Figure 223
View larger version (39K):
[in this window]
[in a new window]

  		Box 2.

 

View this table:
[in this window]
[in a new window]

  		Table 1.

 

Figure 123
View larger version (21K):
[in this window]
[in a new window]

  		Fig. 1: Ten-year absolute risk of fracture for the low-, moderate-and high-risk groups. The presence of a prior fragility fracture or glucocorticoid use increases the fracture risk into the next risk category. Reproduced, with permission, from the Canadian Association of Radiologists (Can Assoc Radiol J 2005;56:178-88).5

 

Figure 323
View larger version (63K):
[in this window]
[in a new window]

  		Box 3.

 

View this table:
[in this window]
[in a new window]

  		Table 2.